16 results
20-F/A
2020 FY
SLN
Silence Therapeutics Plc
29 Apr 21
Annual report (foreign) (amended)
4:26pm
reviewing the structure, size and composition (including the skills, knowledge, experience and diversity) required of our board of directors compared
424B4
SLN
Silence Therapeutics Plc
12 Apr 21
Prospectus supplement with pricing info
11:12am
the structure, size and composition (including the skills, knowledge, experience and diversity) required of our board of directors compared to its
424B4
SLN
Silence Therapeutics Plc
12 Apr 21
Prospectus supplement with pricing info
11:11am
and diversity) required of our board of directors compared to its current position and making recommendations to the board of directors with regard to any
POS AM
fa75q 500tk87jqsn8v7
8 Apr 21
Prospectus update (post-effective amendment)
9:31am
POS AM
rf7z1oh
8 Apr 21
Prospectus update (post-effective amendment)
9:18am
20-F
7fx9uocjz 1k
30 Mar 21
Annual report (foreign)
5:22pm
424B7
3ounuk5330 mop7q6d
15 Mar 21
Prospectus with selling stockholder info
10:07am
F-1/A
u6qwqzo4m wkos1m
11 Mar 21
Registration statement (foreign) (amended)
4:02pm
F-1
3n0s646v xj
8 Mar 21
Registration statement (foreign)
9:50pm
POS AM
exbwg40sjowm
23 Sep 20
Prospectus update (post-effective amendment)
4:47pm
424B4
oa1b vbgw
8 Sep 20
Prospectus supplement with pricing info
7:31am
F-1
h2qmhph2pr28
20 Aug 20
Registration statement (foreign)
4:50pm
DRS/A
w6fqpo mx87o39sm
31 Jul 20
Draft registration statement (amended)
12:00am
DRS
n7qlpe
22 Jun 20
Draft registration statement
12:00am
- Prev
- 1
- Next